Journal of Nutrition LabDiet, Your World of Nutritional Answers

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Medina, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Medina, M. A.
(Journal of Nutrition. 2001;131:2539S-2542S.)
© 2001 The American Society for Nutritional Sciences


Supplement

Glutamine and Cancer1 ,2

Miguel Á. Medina

Department of Molecular Biology and Biochemistry, Faculty of Sciences, University of Málaga, Málaga, Spain

Glutamine is the most abundant free amino acid in the human body; it is essential for the growth of normal and neoplastic cells and for the culture of many cell types. Cancer has been described as a nitrogen trap. The presence of a tumor produces great changes in host glutamine metabolism in such a way that host nitrogen metabolism is accommodated to the tumor-enhanced requirements of glutamine. To be used, glutamine must be transported into tumor mitochondria. Thus, an overview of the role of glutamine in cancer requires not only a discussion of host and tumor glutamine metabolism, but also its circulation and transport. Because glutamine depletion has adverse effects for the host, the effect of glutamine supplementation in the tumor-bearing state should also be studied. This communication reviews the state of knowledge of glutamine and cancer, including potential therapeutic implications.


KEY WORDS: • glutamine • cancer • glutaminase • glutamine synthetase • transglutaminase




This article has been cited by other articles:


Home page
JCBHome page
M. Yuneva, N. Zamboni, P. Oefner, R. Sachidanandam, and Y. Lazebnik
Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells
J. Cell Biol., October 3, 2007; 178(1): 93 - 105.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
A. L. Edinger and C. B. Thompson
Akt Maintains Cell Size and Survival by Increasing mTOR-dependent Nutrient Uptake
Mol. Biol. Cell, July 1, 2002; 13(7): 2276 - 2288.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2001 by American Society for Nutrition